Journey Medical Corp DERM
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $5.95
- Day Range
- $5.89–6.13
- 52-Week Range
- $4.31–9.56
- Bid/Ask
- $4.42 / $6.75
- Shares Outstanding
- 28.22M
- Market Cap
- $167.94M
- Volume/Avg
- 85 / 183,579
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 2.33
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Journey Medical Corp is a commercial-stage pharmaceutical company that focuses on the selling and marketing of U.S. Food and Drug Administration (FDA) approved prescription pharmaceutical products for the treatment of dermatological conditions. Its current product portfolio includes FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. The company views its operations and manages its business in one segment, which reflects products for the treatment of dermatological conditions. The dermatological segment derives revenues from the sale of branded and authorized general prescription products that treat certain dermatological conditions.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Core
- Total Number of Employees
- 58
- Website
- https://www.jmcderm.com
Valuation
|
Metric
|
DERM
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 5.12 |
Price/Sales | 2.33 |
Price/Cash Flow | 33.43 |
Price/Earnings
DERM
Financial Strength
|
Metric
|
DERM
|
|---|---|
Quick Ratio | 1.35 |
Current Ratio | 1.59 |
Interest Coverage | −0.83 |
Quick Ratio
DERM
Profitability
|
Metric
|
DERM
|
|---|---|
Return on Assets (Normalized) | −1.42% |
Return on Equity (Normalized) | −4.57% |
Return on Invested Capital (Normalized) | 2.13% |
Return on Assets
DERM
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Merck KGaA ADR
MKKGY
| LOCK|hQlpqbr | LOCK|vzm&@ | $66B | |||
| Teva Pharmaceutical Industries Ltd
TEVA
| LOCK|d&Md%T@! | LOCK|?qH? | $45B | |||
| Haleon PLC ADR
HLN
| LOCK|hKw$M!! | LOCK|w< | $40B | |||
| Zoetis Inc Class A
ZTS
| LOCK|b#$FnY%X | LOCK|h%Y | $30B | |||
| Viatris Inc
VTRS
| LOCK|gN>#@<b | LOCK|%T< | $20B | |||
| Elanco Animal Health Inc
ELAN
| LOCK|W^C | LOCK|^>Y | $11B | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| LOCK|&LS@y! | LOCK|J% | $10B | |||
| Hims & Hers Health Inc Ordinary Shares - Class A
HIMS
| LOCK|qh$qPJM | LOCK|T@q | $7B | |||
| Prestige Consumer Healthcare Inc
PBH
| LOCK|h#C%K> | LOCK|>DvD& | $2B | |||
| Perrigo Co PLC
PRGO
| LOCK|p$#t#X< | LOCK|<gx | $2B |
United States